Best Value Stocks To Own Right Now


In this episode of Motley Fool Answers, hosts Robert Brokamp and Alison Southwick want to focus on one question — but it’s a big one, especially for long-term investors: When should you sell a stock? To provide the answer, they’ve tapped Motley Fool Chief Investment Officer Andy Cross and Ron Gross, the advisor for Motley Fool Total Income.

In this segment, though, having covered the topic of selling in general, they tackle some questions from listeners. Among them: Is Tesla (NASDAQ: TSLA) overvalued? What was your worst “failure to sell” situation? And how has your investing style changed since you became a Fool?

A full transcript follows the video.

This video was recorded on Aug. 14, 2018.

Ron Gross: A lot of good questions have come in. I think we have some time to tackle some of them. This first one is going to be so painful, though. Painful is in the question. “Please describe a painful ‘failure to sell’ situation you found yourself in.” Any former investors in Horsehead Holding in this room?

Best Value Stocks To Own Right Now: BioDelivery Sciences International Inc.(BDSI)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about BioDelivery Sciences International (NASDAQ:BDSI) have been trending somewhat positive recently, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. BioDelivery Sciences International earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the specialty pharmaceutical company an impact score of 46.960149735727 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe
  • [By Joseph Griffin]

    BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 8,000 shares of the firm’s stock in a transaction on Friday, February 1st. The stock was sold at an average price of $4.60, for a total value of $36,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

  • [By Lisa Levin]

    BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares were also up, gaining 19 percent to $2.3272 after the company announced board restructuring plan and $50m equity financing deal led by Broadfin to "significantly strengthen" financial position.

  • [By Logan Wallace]

    BioDelivery Sciences International (NASDAQ:BDSI) had its target price reduced by research analysts at HC Wainwright from $4.00 to $3.50 in a research report issued to clients and investors on Wednesday. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 40.00% from the company’s current price.

Best Value Stocks To Own Right Now: Archrock, Inc.(AROC)


Advisors’ Opinion:

  • [By Tyler Crowe]

    Oil and gas infrastructure specialist Archrock (NYSE:AROC) and its former subsidiary Archrock Partners were once a textbook case of an overaggressive business that got rocked by crashing oil and gas prices. The company bet heavily on the need for compression horsepower to force oil and gas from wells to pipelines, and took on considerable leverage to do so. When demand dried up from lower production volumes, Archrock was stuck with a fleet of inactive compression equipment and a massive debt load.

  • [By Ethan Ryder]

    News stories about Archrock (NYSE:AROC) have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Archrock earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave headlines about the energy company an impact score of 47.3449329112104 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Tyler Crowe]

    After years of struggling with the precipitous decline in oil prices and an onerous debt load, management at Archrock (NYSE:AROC) decided to bite the bullet and buy out its subsidiary master limited partnership Archrock Partners. According to management, the deal would free up some cash and lower its cost of capital. The combination of these two things would make it easier to grow the business and take advantage of the monumental growth of natural gas production in the U.S.

  • [By ]

    As it happens, I am familiar with about half of these stocks. Archrock (Nasdaq: AROC), Qualcomm (Nasdaq: QCOM), Schlumberger (NYSE: SLB, and Trinity Industries (NYSE: TRN) are all interesting names that I’ve either owned in the past or have written about recently over at High-Yield Investing.

Best Value Stocks To Own Right Now: Greif Bros. Corporation(GEF.B)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Greif, Inc. Class B (NYSE:GEF.B) declared a quarterly dividend on Tuesday, June 5th, Zacks reports. Stockholders of record on Monday, June 18th will be given a dividend of 0.63 per share by the industrial products company on Sunday, July 1st. This represents a $2.52 dividend on an annualized basis and a dividend yield of 4.18%. The ex-dividend date is Friday, June 15th.

Best Value Stocks To Own Right Now: Woori Bank(WF)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Wells Fargo (WF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    News headlines about Woori Bank (NYSE:WF) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Woori Bank earned a news sentiment score of 0.19 on Accern’s scale. Accern also assigned press coverage about the bank an impact score of 46.2147954877183 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Stephan Byrd]

    Woori Bank (NYSE:WF) and ANZ (OTCMKTS:ANZBY) are both large-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Best Value Stocks To Own Right Now: Citi Trends, Inc.(CTRN)

Advisors’ Opinion:

  • [By Logan Wallace]

    COPYRIGHT VIOLATION WARNING: “Assenagon Asset Management S.A. Lowers Stake in Citi Trends, Inc. (CTRN)” was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4116950/assenagon-asset-management-s-a-lowers-stake-in-citi-trends-inc-ctrn.html.

  • [By Stephan Byrd]

    Citi Trends (NASDAQ:CTRN) will issue its quarterly earnings data before the market opens on Wednesday, May 23rd. Analysts expect the company to announce earnings of $0.90 per share for the quarter. Citi Trends has set its FY19 guidance at $1.55-1.70 EPS.

  • [By Logan Wallace]

    Citi Trends (NASDAQ: CTRN) and Hanesbrands (NYSE:HBI) are both retail/wholesale companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

  • [By Motley Fool Transcribers]

    Citi Trends Inc (NASDAQ:CTRN)Q2 2018 Earnings Conference CallAug. 23, 2018, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Leave a Reply

Your email address will not be published.